Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection
Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by h...
Saved in:
Published in | BMC cancer Vol. 9; no. 1; p. 329 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
16.09.2009
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection.
Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively.
A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues.
Differential AP-1 binding activity and expression of its specific proteins between HPV--positive and HPV--negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. |
---|---|
AbstractList | BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. METHODS: Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. RESULTS: A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. CONCLUSION: Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Doc number: 329 Abstract Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods: Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results: A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion: Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Differential AP-1 binding activity and expression of its specific proteins between HPV--positive and HPV--negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis. |
ArticleNumber | 329 |
Audience | Academic |
Author | Hussain, Showket Mir, Mohammad Muzaffar Salam, Irfana Bhat, Mohammad Akbar Das, Bhudev C Hedau, Suresh Siddiqi, Mushtaq A Basir, Seemi Farhat Bharti, Alok C |
AuthorAffiliation | 2 Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India 4 Department of Immunology and Molecular Medicine Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India 5 Department of Biosciences, Jamia Millia Islamai; New Delhi, India 6 Dr. B.R. Ambedkar Research Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi, India 1 Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), I-7, Sector-39, Noida, India 3 Department of Cardiovascular and Thoracic Surgery, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India |
AuthorAffiliation_xml | – name: 4 Department of Immunology and Molecular Medicine Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India – name: 5 Department of Biosciences, Jamia Millia Islamai; New Delhi, India – name: 6 Dr. B.R. Ambedkar Research Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi, India – name: 2 Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India – name: 3 Department of Cardiovascular and Thoracic Surgery, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India – name: 1 Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), I-7, Sector-39, Noida, India |
Author_xml | – sequence: 1 givenname: Showket surname: Hussain fullname: Hussain, Showket email: shussain1712@yahoo.co.in organization: Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), Noida, India. shussain1712@yahoo.co.in – sequence: 2 givenname: Alok C surname: Bharti fullname: Bharti, Alok C – sequence: 3 givenname: Irfana surname: Salam fullname: Salam, Irfana – sequence: 4 givenname: Mohammad Akbar surname: Bhat fullname: Bhat, Mohammad Akbar – sequence: 5 givenname: Mohammad Muzaffar surname: Mir fullname: Mir, Mohammad Muzaffar – sequence: 6 givenname: Suresh surname: Hedau fullname: Hedau, Suresh – sequence: 7 givenname: Mushtaq A surname: Siddiqi fullname: Siddiqi, Mushtaq A – sequence: 8 givenname: Seemi Farhat surname: Basir fullname: Basir, Seemi Farhat – sequence: 9 givenname: Bhudev C surname: Das fullname: Das, Bhudev C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19758438$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktr3DAUhU1JaR7tursiuih04UaybMnqIjANfQwEGtp0La4l2aNgSxPJHpIf0f9cOTOkM9CuJHTP-bi6555mR847k2WvCf5ASM3OSclJXpSY5yKnhXiWnTy9HO3dj7PTGG8xJrzG9YvsmAhe1SWtT7LfNwFcVMGuR-sdakGNPqDFdU6QdchEv15BZ6BH8W6CwU8RKdP3SEFQ1vkBPiLoRxNgdsfZkgB2Y8cHBE4jc78OJsaZrKdgXYdW0wAOXcPa9n2yb2yYZltr1Ex4mT1voY_m1e48y359-Xxz-S2_-v51ebm4yhvGqzHXLaGMMUqoaWqNlWgEV7gGpkrFqko3UBjKSKupUYIxXpuKadJWbWtYyQTQs2y55WoPt3Id7ADhQXqw8vHBh05CGK3qjWS6aRXXnJe6KMu2qA3nSpGiotRgWuPEutiy1lMzGK2MGwP0B9DDirMr2fmNLFIGAs-AT1tAY_1_AIcV5Qc5RyvnaKWQKfgEebvrIvi7ycRR3vopuDREKQQVIg2hSKL3W1EH6WfWKe9Gcz92MMUolz9_yEWBBRG4pjxp3-1pV2kFxlX0_fQY9KHwfCtUwccYTPvUOcFyXtJ_9Ppmf2J_9butpH8AIZbm_w |
CitedBy_id | crossref_primary_10_1007_s13402_011_0056_2 crossref_primary_10_1007_s13277_015_4248_7 crossref_primary_10_1155_2011_263216 crossref_primary_10_3389_fcimb_2020_537650 crossref_primary_10_1002_cam4_884 crossref_primary_10_1038_s41598_018_27699_1 crossref_primary_10_1016_j_oraloncology_2022_106198 crossref_primary_10_1038_s41417_024_00738_y crossref_primary_10_1111_j_1743_7563_2012_01555_x crossref_primary_10_1371_journal_pone_0098642 crossref_primary_10_3109_10799893_2011_553836 crossref_primary_10_18632_oncotarget_5832 crossref_primary_10_1007_s11033_019_05123_9 crossref_primary_10_1038_srep07822 crossref_primary_10_3389_fonc_2021_724687 crossref_primary_10_1016_j_semcancer_2021_05_031 crossref_primary_10_1016_j_tice_2022_102010 crossref_primary_10_1016_j_ygyno_2012_11_041 crossref_primary_10_1007_s13277_015_4378_y crossref_primary_10_1016_j_lfs_2018_02_025 crossref_primary_10_1007_s00005_013_0263_9 crossref_primary_10_18632_oncotarget_26041 crossref_primary_10_2217_fvl_13_116 crossref_primary_10_1038_srep16811 crossref_primary_10_1371_journal_ppat_1005366 crossref_primary_10_3109_00365548_2012_702281 crossref_primary_10_1002_mc_20732 crossref_primary_10_1002_jcb_28716 crossref_primary_10_3109_10799891003786218 |
Cites_doi | 10.1016/j.vaccine.2006.05.111 10.3748/wjg.v10.i4.476 10.1002/ijc.20668 10.1093/carcin/13.11.2179 10.3748/wjg.v12.i25.4033 10.1128/jvi.66.6.3740-3748.1992 10.1038/sj.bjc.6603375 10.1006/geno.1993.1447 10.1016/S0014-4827(03)00346-X 10.1200/JCO.2006.06.1291 10.1016/S0955-0674(97)80068-3 10.1136/jcp.55.10.721 10.1128/jvi.71.1.362-370.1997 10.1002/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F 10.1136/jech.47.4.290 10.1038/ncb0502-e131 10.1007/BF00397910 10.1016/0076-6879(90)82017-V 10.3322/canjclin.55.2.74 10.1038/ng790 10.1016/j.ygyno.2006.01.058 10.1016/j.gassur.2005.09.003 10.1099/0022-1317-73-9-2327 10.1038/35065000 10.1038/sj.onc.1202765 10.1016/0360-3016(94)00419-L 10.1002/(SICI)1097-0215(19990412)81:2<225::AID-IJC10>3.0.CO;2-0 10.1136/gut.33.1.11 10.1074/jbc.M203519200 10.1002/1097-0215(200002)9999:9999<::AID-IJC1095>3.0.CO;2-J 10.1146/annurev.cb.06.110190.002543 10.1016/j.canlet.2004.09.003 10.1158/1541-7786.MCR-06-0311 10.1002/ijc.22262 10.1128/jvi.64.10.4792-4798.1990 10.1016/j.vaccine.2008.03.056 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2009 BioMed Central Ltd. 2009 Hussain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2009 Hussain et al; licensee BioMed Central Ltd. 2009 Hussain et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2009 BioMed Central Ltd. – notice: 2009 Hussain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2009 Hussain et al; licensee BioMed Central Ltd. 2009 Hussain et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 5PM DOA |
DOI | 10.1186/1471-2407-9-329 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Science In Context ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
EndPage | 329 |
ExternalDocumentID | oai_doaj_org_article_6dbfc7d774d244f28e77cc12533e0380 oai_biomedcentral_com_1471_2407_9_329 2631023781 A209190837 10_1186_1471_2407_9_329 19758438 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 3V. 4.4 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C1A C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR IPNFZ ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO 7TO 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS ABVAZ AFNRJ 5PM |
ID | FETCH-LOGICAL-b675t-df13666313eb8d0c9b97c08a6c4c655dba2e361fd3ec96678e56d1f5ffe6469a3 |
IEDL.DBID | RBZ |
ISSN | 1471-2407 |
IngestDate | Tue Oct 22 15:15:15 EDT 2024 Tue Sep 17 21:25:22 EDT 2024 Wed May 22 07:11:11 EDT 2024 Thu Oct 10 19:26:57 EDT 2024 Thu Aug 01 19:46:50 EDT 2024 Tue Aug 20 22:01:00 EDT 2024 Thu Sep 12 17:47:24 EDT 2024 Sat Sep 28 07:48:34 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b675t-df13666313eb8d0c9b97c08a6c4c655dba2e361fd3ec96678e56d1f5ffe6469a3 |
OpenAccessLink | http://dx.doi.org/10.1186/1471-2407-9-329 |
PMID | 19758438 |
PQID | 993996782 |
PQPubID | 44074 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6dbfc7d774d244f28e77cc12533e0380 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2758900 biomedcentral_primary_oai_biomedcentral_com_1471_2407_9_329 proquest_journals_993996782 gale_incontextgauss_ISR_A209190837 gale_healthsolutions_A209190837 crossref_primary_10_1186_1471_2407_9_329 pubmed_primary_19758438 |
PublicationCentury | 2000 |
PublicationDate | 2009-09-16 |
PublicationDateYYYYMMDD | 2009-09-16 |
PublicationDate_xml | – month: 09 year: 2009 text: 2009-09-16 day: 16 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cancer |
PublicationTitleAlternate | BMC Cancer |
PublicationYear | 2009 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 17314269 - Mol Cancer Res. 2007 Feb;5(2):109-20 18455843 - Vaccine. 2008 May 23;26(22):2669-79 14966901 - World J Gastroenterol. 2004 Feb 15;10(4):476-80 10188723 - Int J Cancer. 1999 Apr 12;81(2):225-8 16563473 - Gynecol Oncol. 2006 Oct;103(1):100-5 18219112 - Cell Oncol. 2008;30(1):77-87 19653276 - Int J Cancer. 2010 Feb 15;126(4):819-29 2715165 - J Cancer Res Clin Oncol. 1989;115(2):111-7 2168967 - J Virol. 1990 Oct;64(10):4792-8 15514944 - Int J Cancer. 2005 Mar 1;113(6):951-60 12354793 - J Clin Pathol. 2002 Oct;55(10):721-8 15639342 - Cancer Lett. 2005 Jan 31;218(1):69-79 2314237 - Methods Enzymol. 1990;182:194-203 1740265 - Gut. 1992 Jan;33(1):11-5 7713784 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1213-36 2125830 - Annu Rev Cell Biol. 1990;6:539-57 1330353 - Carcinogenesis. 1992 Nov;13(11):2179-82 8276409 - Genomics. 1993 Oct;18(1):165 17060942 - Br J Cancer. 2006 Nov 6;95(9):1250-7 8228764 - J Epidemiol Community Health. 1993 Aug;47(4):290-2 16998793 - Int J Cancer. 2006 Dec 15;119(12):2840-50 10359524 - Oncogene. 1999 May 27;18(21):3187-98 16949997 - Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25 11818961 - Nat Genet. 2002 Feb;30(2):158-66 9133458 - Int J Cancer. 1997 Apr 22;74(2):212-9 16810754 - World J Gastroenterol. 2006 Jul 7;12(25):4033-7 11489794 - Clin Cancer Res. 2001 Aug;7(8):2213-21 14597411 - Exp Cell Res. 2003 Nov 15;291(1):91-100 9069263 - Curr Opin Cell Biol. 1997 Apr;9(2):240-6 15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 12082101 - J Biol Chem. 2002 Sep 6;277(36):32668-76 8985358 - J Virol. 1997 Jan;71(1):362-70 11267971 - Int J Cancer. 2001 Mar 1;91(5):625-30 11988758 - Nat Cell Biol. 2002 May;4(5):E131-6 1316480 - J Virol. 1992 Jun;66(6):3740-8 16627221 - J Gastrointest Surg. 2006 Apr;10(4):551-62 1751545 - Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57 16763272 - J Clin Oncol. 2006 Jun 10;24(17):2606-11 1328489 - J Gen Virol. 1992 Sep;73 ( Pt 9):2327-36 11242034 - Nature. 2001 Mar 1;410(6824):37-40 DM Parkin (1663_CR1) 2005; 55 T Li (1663_CR30) 2002; 277 KY Lam (1663_CR6) 1997; 74 U Kailash (1663_CR18) 2006; 95 MM Abdel-Latif (1663_CR27) 2006; 10 DM Parkin (1663_CR7) 2006; 24 P Angel (1663_CR24) 1991; 1072 M Karin (1663_CR25) 1997; 9 A Mishra (1663_CR14) 2006; 119 BC Das (1663_CR38) 2008; 26 M Siddiqi (1663_CR2) 1989; 115 I Murtaza (1663_CR5) 2006; 12 R Kumar (1663_CR3) 1992; 13 YC Hu (1663_CR33) 2001; 7 GM Dhar (1663_CR28) 1993; 47 S Katiyar (1663_CR9) 2005; 218 A Mishra (1663_CR37) 2009 MY Wu (1663_CR32) 2004; 10 E Passegue (1663_CR29) 2002; 30 NV Shirsat (1663_CR36) 2003; 291 1663_CR16 BK Prusty (1663_CR21) 2005; 113 L Chang (1663_CR22) 2001; 410 NR Datta (1663_CR41) 2006; 103 BC Das (1663_CR17) 1992; 73 EA Offord (1663_CR10) 1990; 64 U Soto (1663_CR34) 1999; 18 RJ Sinke (1663_CR35) 1993; 18 F Thierry (1663_CR12) 1992; 66 MS Khuroo (1663_CR4) 1992; 33 J de Wilde (1663_CR13) 2008; 30 EM de Villiers (1663_CR39) 1999; 81 C Fakhry (1663_CR40) 2006; 24 KJ Syrjanen (1663_CR8) 2002; 55 JD Dignam (1663_CR19) 1990; 182 CM Robinson (1663_CR31) 2001; 91 F Rosl (1663_CR20) 1997; 71 LJ Ransone (1663_CR23) 1990; 6 MV Karamouzis (1663_CR11) 2007; 5 E Shaulian (1663_CR26) 2002; 4 LR Coia (1663_CR15) 1995; 31 |
References_xml | – volume: 24 start-page: 11 issue: Suppl 3 year: 2006 ident: 1663_CR7 publication-title: Vaccine doi: 10.1016/j.vaccine.2006.05.111 contributor: fullname: DM Parkin – volume: 10 start-page: 476 year: 2004 ident: 1663_CR32 publication-title: World J Gastroenterol doi: 10.3748/wjg.v10.i4.476 contributor: fullname: MY Wu – volume: 113 start-page: 951 year: 2005 ident: 1663_CR21 publication-title: Int J Cancer doi: 10.1002/ijc.20668 contributor: fullname: BK Prusty – volume: 13 start-page: 2179 year: 1992 ident: 1663_CR3 publication-title: Carcinogenesis doi: 10.1093/carcin/13.11.2179 contributor: fullname: R Kumar – volume: 12 start-page: 4033 year: 2006 ident: 1663_CR5 publication-title: World J Gastroenterol doi: 10.3748/wjg.v12.i25.4033 contributor: fullname: I Murtaza – volume: 66 start-page: 3740 year: 1992 ident: 1663_CR12 publication-title: J Virol doi: 10.1128/jvi.66.6.3740-3748.1992 contributor: fullname: F Thierry – volume: 95 start-page: 1250 year: 2006 ident: 1663_CR18 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603375 contributor: fullname: U Kailash – volume: 18 start-page: 165 year: 1993 ident: 1663_CR35 publication-title: Genomics doi: 10.1006/geno.1993.1447 contributor: fullname: RJ Sinke – volume: 291 start-page: 91 year: 2003 ident: 1663_CR36 publication-title: Exp Cell Res doi: 10.1016/S0014-4827(03)00346-X contributor: fullname: NV Shirsat – volume: 24 start-page: 2606 year: 2006 ident: 1663_CR40 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.1291 contributor: fullname: C Fakhry – volume: 9 start-page: 240 year: 1997 ident: 1663_CR25 publication-title: Curr Opin Cell Biol doi: 10.1016/S0955-0674(97)80068-3 contributor: fullname: M Karin – volume: 55 start-page: 721 year: 2002 ident: 1663_CR8 publication-title: J Clin Pathol doi: 10.1136/jcp.55.10.721 contributor: fullname: KJ Syrjanen – volume: 71 start-page: 362 year: 1997 ident: 1663_CR20 publication-title: J Virol doi: 10.1128/jvi.71.1.362-370.1997 contributor: fullname: F Rosl – volume: 74 start-page: 212 year: 1997 ident: 1663_CR6 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F contributor: fullname: KY Lam – volume: 30 start-page: 77 year: 2008 ident: 1663_CR13 publication-title: Cell Oncol contributor: fullname: J de Wilde – volume: 47 start-page: 290 year: 1993 ident: 1663_CR28 publication-title: J Epidemiol Community Health doi: 10.1136/jech.47.4.290 contributor: fullname: GM Dhar – volume: 4 start-page: E131 year: 2002 ident: 1663_CR26 publication-title: Nat Cell Biol doi: 10.1038/ncb0502-e131 contributor: fullname: E Shaulian – volume: 115 start-page: 111 year: 1989 ident: 1663_CR2 publication-title: J Cancer Res Clin Oncol doi: 10.1007/BF00397910 contributor: fullname: M Siddiqi – volume: 182 start-page: 194 year: 1990 ident: 1663_CR19 publication-title: Methods Enzymol doi: 10.1016/0076-6879(90)82017-V contributor: fullname: JD Dignam – volume: 55 start-page: 74 year: 2005 ident: 1663_CR1 publication-title: CA Cancer J Clin doi: 10.3322/canjclin.55.2.74 contributor: fullname: DM Parkin – volume: 30 start-page: 158 year: 2002 ident: 1663_CR29 publication-title: Nat Genet doi: 10.1038/ng790 contributor: fullname: E Passegue – volume: 103 start-page: 100 year: 2006 ident: 1663_CR41 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2006.01.058 contributor: fullname: NR Datta – volume: 10 start-page: 551 year: 2006 ident: 1663_CR27 publication-title: J Gastrointest Surg doi: 10.1016/j.gassur.2005.09.003 contributor: fullname: MM Abdel-Latif – volume: 73 start-page: 2327 issue: Pt 9 year: 1992 ident: 1663_CR17 publication-title: J Gen Virol doi: 10.1099/0022-1317-73-9-2327 contributor: fullname: BC Das – volume: 410 start-page: 37 year: 2001 ident: 1663_CR22 publication-title: Nature doi: 10.1038/35065000 contributor: fullname: L Chang – ident: 1663_CR16 – volume: 1072 start-page: 129 year: 1991 ident: 1663_CR24 publication-title: Biochim Biophys Acta contributor: fullname: P Angel – volume: 18 start-page: 3187 year: 1999 ident: 1663_CR34 publication-title: Oncogene doi: 10.1038/sj.onc.1202765 contributor: fullname: U Soto – volume: 31 start-page: 1213 year: 1995 ident: 1663_CR15 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(94)00419-L contributor: fullname: LR Coia – volume: 81 start-page: 225 year: 1999 ident: 1663_CR39 publication-title: Int J Cancer doi: 10.1002/(SICI)1097-0215(19990412)81:2<225::AID-IJC10>3.0.CO;2-0 contributor: fullname: EM de Villiers – volume: 33 start-page: 11 year: 1992 ident: 1663_CR4 publication-title: Gut doi: 10.1136/gut.33.1.11 contributor: fullname: MS Khuroo – volume: 277 start-page: 32668 year: 2002 ident: 1663_CR30 publication-title: J Biol Chem doi: 10.1074/jbc.M203519200 contributor: fullname: T Li – volume: 91 start-page: 625 year: 2001 ident: 1663_CR31 publication-title: Int J Cancer doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1095>3.0.CO;2-J contributor: fullname: CM Robinson – volume: 7 start-page: 2213 year: 2001 ident: 1663_CR33 publication-title: Clin Cancer Res contributor: fullname: YC Hu – volume-title: Int J Cancer year: 2009 ident: 1663_CR37 contributor: fullname: A Mishra – volume: 6 start-page: 539 year: 1990 ident: 1663_CR23 publication-title: Annu Rev Cell Biol doi: 10.1146/annurev.cb.06.110190.002543 contributor: fullname: LJ Ransone – volume: 218 start-page: 69 year: 2005 ident: 1663_CR9 publication-title: Cancer Lett doi: 10.1016/j.canlet.2004.09.003 contributor: fullname: S Katiyar – volume: 5 start-page: 109 year: 2007 ident: 1663_CR11 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-06-0311 contributor: fullname: MV Karamouzis – volume: 119 start-page: 2840 year: 2006 ident: 1663_CR14 publication-title: Int J Cancer doi: 10.1002/ijc.22262 contributor: fullname: A Mishra – volume: 64 start-page: 4792 year: 1990 ident: 1663_CR10 publication-title: J Virol doi: 10.1128/jvi.64.10.4792-4798.1990 contributor: fullname: EA Offord – volume: 26 start-page: 2669 year: 2008 ident: 1663_CR38 publication-title: Vaccine doi: 10.1016/j.vaccine.2008.03.056 contributor: fullname: BC Das |
SSID | ssj0017808 |
Score | 2.1201956 |
Snippet | Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of... Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A... Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial... Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of... Doc number: 329 Abstract Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of... BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial... Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 329 |
SubjectTerms | Adult Aged Aged, 80 and over Alphapapillomavirus - physiology Binding sites Biomedical research Cancer therapies Carcinoma, Squamous Cell - genetics Carcinoma, Squamous Cell - metabolism Carcinoma, Squamous Cell - virology Cervical cancer Complications and side effects Deoxyribonucleic acid DNA Dysphagia Esophageal cancer Esophageal Neoplasms - genetics Esophageal Neoplasms - metabolism Esophageal Neoplasms - virology Female Gene expression Gene Expression Regulation, Neoplastic Genetic aspects Genetic testing Human papillomavirus Humans India Male Middle Aged Papillomavirus infections Papillomavirus Infections - genetics Papillomavirus Infections - metabolism Papillomavirus Infections - virology Physiological aspects Protein Binding Risk factors Studies Surgery Thoracic surgery Transcription Factor AP-1 - genetics Transcription Factor AP-1 - metabolism Transcription factors Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k0oDwtx4GI1juPYhtOCqApSUQVU6s1ybAdWWtLS3UX8Cf4zM3Z2WasHLlxjTyRnJjPfeF6EvJC9cU0rBatdcFiS0zInuGDKt1FLMPg81VYdf-yOTtsPZ_JsZ9QX5oTl9sD5wx10oR-8CoBSAliiodFRKe_BLAsRa6Gzt16bjTM1xQ-UTrPoOKhejB-oqakP193B9hkzTCCyLArdF4V9Sm38ryrrHWtVZlLumKbDW-TmhCnpLJ_lNrkWxzvk-vEUNb9LfieDtFEPNI_YobMTxul8pBEHGYBWgTcsf6wdXgVQvM6nHscMjeff3Ss6W6TmyyiiSILFEDhzgrox0PhryqUdaa55pCkwQE_cxXyxAPKf88s1kuWsr_EeOT189-XtEZvGMLAevIkVCwMX4OQAB2OvQ-1Nb5Svtet86zspQ--aKDo-BBE9OE9KR9kFPshhiB04307cJ3vj-RgfEur6wSjXAASSGO5se82Vl_3A-SCc4k1FXhfMsBe55YbFJtjlCvyPFllpkZXWWGBlRV5uWLclTD6O7q5ufYOsLd6fHoDo2Un07L9EryLPUDBsrljdqgo7awCEGcC2qiLP0w5stDFiJs9Xt14u7fvPn4pN-xvBspMCWVqAjeCJAnyryIMsYn-PZMDHa4WuiCqErzhMuTLOv6XO4Q1Qmrp-9D9Ov09u5MiaYbx7TPZWl-v4BADaqn-a_sU_t0841w priority: 102 providerName: Directory of Open Access Journals – databaseName: PubMed Central dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJtQHhbiwCXdOI5jB05LRVWQFq2ASr1ZtuO0kbLe7T4q_gT_mbHjlEa9cU08UawZz3zjeSH0nulK5QWjaaZq5UtyilRRQlNuCisYGHwSaqtm38vTs-LbOTvfQ2yohQlJ-0a3R65bHLn2MuRWrhZmMuSJTeaz4xxAbpVlk320DwI6uOgxdMBFJmIPHyLKCQHt60MIPK1SmvdNQoG88AUpoxL3bmSZQgP_u2r6lp0a51DeMkonD9GDiCbxtP_rR2jPusfo3izGy5-gP8EUDYoB98N18HSeEtw6bP0IA9An8IXN1U75SwDsL_Kx8QOG3HKhPuJpF9oue-H0JL4Mwk-bwMrV2P6OWbQO99WOOIQE8Fyt2q4D8ut2vfNkfb6Xe4rOTr78Oj5N4wCGVIMfsU3rhlBwb4B3Vos6M5WuuMmEKk1hSsZqrXJLS9LU1Bpwm7iwrKxJw5rGluB2K_oMHbilsy8QVrqpuMoB_DAf6Cy0INww3RDSUMVJnqBPI2bIVd9sQ_r21-M3cBKl56r0XJWVBK4m6MPAuhvC4N2I8u7Sz561o--HB8v1hYxCJstaN4bXAI1rgD9NLiznxgAWpNRmVGQJeusFQ_a1qjdKQk5zgF8VoFqeoHdhhW-x4XwOz4XabTby688fo0WHg2DJqDo2EgAj-KAA3BL0vBexf1uKkpsgPhK-0WbGb-AIhZ7h8ci8_G_KQ3S_D6RVKSlfoYPtemdfAx7b6jfh_P0FIvc3uw priority: 500 providerName: National Library of Medicine – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k1aHhbiwCVqHCexAwe0IKqCVFQBlfZmObZTVlq8281uxZ_gPzPjeJdalbjGnkTWTGa-8bwIeV13rS6rmueFthpLcqpcc8ZzYSonazD4LNRWnXxtjs-qL9N6GnNzhphWudWJQVHbhcE78kOwowDNwZ69X17kODQKg6txgsZNcouVRYMZXWK687eYkIWM3XyYbA4Z6GEMJoi8zTlCyqTCfZ4YptC__7qWvmKm0hTKKzbp6B65G8EknYzcv09uOP-A3D6J4fKH5E-wRFu9QMfZOnRymjM689ThBANQJ_CG4WKj8Q6A4j0-NThfyC9-6bd0Mg9dl1E2kQSrIHDYBNXeUvc7JtF6OhY70hARoKd6OZvPgfxyttog2Zju5R-Rs6NPPz4e53H-Qt6BG7HObc84eDfAOtdJW5i2a4UppG5MZZq6tp0uHW9Yb7kz4DUJ6erGsr7ue9eA1635Y7LnF949JVR3fSt0Cdinxjhn1UkmTN31jPVcC1Zm5F3CDLUce20o7H6droBQKGSlQlaqVgErM_Jmy7odYXBuZHN96wdkbfL-8GCxOlfxZ1WN7XojLCBjC-inL6UTwhiAgpy7gssiIy9RMNRYqrrTEWpSAvpqAdSKjLwKO7DDhscUnnO9GQb1-fu3ZNPBVrBU1ByD2sl5Rp6MIvbvSC04dxWXGRGJ8CWHSVf87GdoGV4CZVsU-__94gG5M8bK8ILpGdlbrzbuOUCudfci_Fh_AbnYLnM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELagSIgL4k0oDwtx4BKI4zh2QAgtiKogLaqAlXqzHNspKy3edh-o_Aj-MzNOtlur5brxeJXM6xuPZ4aQF6JtTFkJnhfGGSzJqXLDGc-lrbwS4PBZrK0af633J9WXQ3G4HQc0fMDlpaEdzpOaLGavTk_-vAeFfxcVXtWvGRhYzBLIvMl52Vwl10r4U5zjMK62KQWpCjX09rmEKDYPBexcYaFKUvo-SzxWbOx_0Xyf81_p3cpzzmrvFrk5oEw66sXiNrniwx1yfTzk0e-Sv9FFbQwG7Yfu0NFBzug0UI-jDcDOwA7Lk7XBwwGKB_zU4uChMP9l3tCYZe9P-5AEyyNwCgU1wVF_OtyuDbSvgqRxEiA9MMfT2QzIf08XayTr74GFe2Sy9-nHx_18GMyQtxBfrHLXMQ5hD_DUt8oVtmkbaQtlalvZWgjXmtLzmnWOewvhlFRe1I51out8DeG44ffJTpgH_5BQ03aNNCWAIoEJ0KpVTFrRdox13EhWZuRtwgx93Dfh0NgWO30CGqqRqxq5qhsNXM3Iyw3rzghj1KPqi0s_IGuT_eMP88WRHrRY167trHQAmR3Aoq5UXkprASNy7guuiow8Q8HQfQ3rmfHQoxJgWQNoV2bkeVyBrTcC3u05MuvlUn_-_i1ZtLsRLL3RCA1AEmJTAHQZedCL2PaVBsnNiEyEL3mZ9EmY_oy9xEugbIri0X_33CU3-gRak7P6MdlZLdb-CeCwVfs06tc_l7QxQQ priority: 102 providerName: Scholars Portal |
Title | Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19758438 https://www.proquest.com/docview/993996782 http://dx.doi.org/10.1186/1471-2407-9-329 https://pubmed.ncbi.nlm.nih.gov/PMC2758900 https://doaj.org/article/6dbfc7d774d244f28e77cc12533e0380 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZoKyEuiH9CIViIA5eIOI5jG067qFVB2mpVqLTiYjmODSstaenuIl6Cd2bGyW6blhuXHBKPJWfGM994PDOEvBa1tkUpeJbbxmJKTplZzngmXemVAIPPYm7V5Lg6Oi0_zcTsslj0tQg-U9VbBuoTYwAy0xkv9A7ZK7CiCjrm46_bgIFUsfncdnBfxecfE1zLbF8MDFKs239TO18xT8Ork1ds0eE9crcHkXTUcf0-ueXbB-T2pA-TPyR_ogXa6APa9dSho2nG6LylHjsXgBqBGZY_1xZ9f4rn99RhX6H27Id9R0eLWG0ZZRJJMPsBm0xQ2zbU_-4vz7a0S3KkMRJAp_Z8vlgA-a_5xRrJumte7SNyenjw5cNR1vddyGpwH1ZZExgHrwZY5mvV5E7XWrpc2cqVrhKiqW3hecVCw70Db0kqL6qGBRGCr8Dbtvwx2W3PWv-UUFsHLW0BmEdgfLOsFZNO1IGxwK1kRULeD5hhzrsaGwarXg-_wAY0yEqDrDTaACsT8mbDui1hdGpUdXPoGFk7mD--AFEz_SY1VVMHJxtAxA2gnlAoL6VzAAE59zlXeUJeomCYLkV1qxvMqADUpQHMyoS8iiOwskaLV3e-2fVyaT5-PhkM2t8Iluk1xtIATgTXE_BaQp50Ina5JA1OXclVQuRA-AaLGX5p599jqfACKHWeP_uv37xP7nQxNJ0V6jnZXV2s_QuAYqs6JTtyJlOyNz44np6k8UADnpNSpXF7pvH07C88ujbK |
link.rule.ids | 108,230,315,730,783,787,867,888,2109,2228,12068,21400,24330,24949,27936,27937,31731,33756,43322,43817,53804,53806,76140,76141 |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgk4AXxDdhwCzEAy_W4jiJE3hAHdrUwVpVY5P2Zvkro1JJu6ZF_BP8z9wlblk0idfYl8i6y93vfF-EvM9MqZM0EyzWTmNJTsq04IJJm_oiA4PP29qq0TgfXqRfL7PLkJvThLTKjU5sFbWbW7wjPwA7CtAc7NnnxTXDoVEYXA0TNO6SXexUBb7X7uHReHK2DSPIIi5CPx9e5AccNDGGEyQrmUBQ2atxn_VMU9vB_7aevmGo-kmUN6zS8SPyMMBJOuj4_5jc8fUTcm8UAuZPyZ_WFm00A-2m69DBhHE6ranHGQagUOANzfVa4y0AxZt8anHCUD3_qT_Swaztu4zSiSRYB4HjJqiuHfW_QxptTbtyR9rGBOhEL6azGZD_mi7XSNYlfNXPyMXx0fmXIQsTGJgBR2LFXMUF-DfAPG8KF9vSlNLGhc5tavMsc0YnXuS8csJb8Jtk4bPc8SqrKp-D363Fc7JTz2v_klBtqlLqBNBPhpHO1AC_bGYqziuhJU8i8qnHDLXoum0o7H_dXwGxUMhKhaxUpQJWRuTDhnVbwta9KfLbWw-Rtb33tw_myysVfleVO1NZ6QAbO8A_VVJ4Ka0FMCiEj0URR2QfBUN1xapbLaEGCeCvEmCtjMi7dgf22KgxiedKr5tGnXw_623a2wiWCrqjUVtJj8iLTsT-HakE9w5EPSKyJ3y9w_RX6umPtml4ApRlHL_67xf3yf3h-ehUnZ6Mv-2RB13krGQ8f012Vsu1fwMAbGXeht_sLy1YMtc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKkSouqDwbCtRCHLiExnES23DaQlct0GpVqFRxsfwsK7bZ7T4Qf4L_zNjJLhvKjVuUeCw5M575xuOZQehlqYXKi5KmmbIqpOQUqaKEpswUjpdg8EnMrTo5rY7Oiw8X5cUGOlzmwuirMKVx09fr6eejqLPhwXzfn1jfbHVe7RNQrSE-wFKR0lzcQrfBKy9CB4ezg6-rYALjsTHdanBb4ecfE_yV9T7qGKtY0_-m5l4zXd1rlWt2qr-N7rYAE_caibiHNlx9H22dtCH0B-hXtE5LXYGbfju4N0gJHtbYha4GoGJghtn1QoVzARzO9rEJPYfq8ZV6g3ujWIk5yGsgCZkRoQEFVrXF7md7sbbGTQIkjlECPFCT4WgE5D-G00Uga66A1Q_Ref_wy7ujtO3JkGpwLeap9YSCxwPsdJrbzAgtmMm4qkxhqrK0WuWOVsRb6gx4Uoy7srLEl967CjxxRR-hzXpcux2ElfaCqRzwUBlin4XmhJlSe0I8VYzkCXrbYYacNPU3ZKiI3f0C0iEDK2VgpRQSWJmgV0vWrQijw8Orm0MPAms788cX4-mlbDewrKz2hllAyxYQkc-5Y8wYgIeUuozyLEF7QTBkk7660huylwMiEwB0WYJexBGh6kYdrvVcqsVsJo8_n3UG7S4FS7baZCYBQ4JbClguQY8bEfuzJAEOX0F5glhH-DqL6X6ph99iGfEcKEWWPfmv37yHtgbv-_LT8enHXXSnCbWJlFRP0eZ8unDPALHN9fO4H38Dhvo-_Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcription+factor+AP-1+in+esophageal+squamous+cell+carcinoma%3A+alterations+in+activity+and+expression+during+human+Papillomavirus+infection&rft.jtitle=BMC+cancer&rft.au=Hussain%2C+Showket&rft.au=Bharti%2C+Alok+C&rft.au=Salam%2C+Irfana&rft.au=Bhat%2C+Mohammad+Akbar&rft.date=2009-09-16&rft.eissn=1471-2407&rft.volume=9&rft.spage=329&rft_id=info:doi/10.1186%2F1471-2407-9-329&rft_id=info%3Apmid%2F19758438&rft.externalDocID=19758438 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |